Arrowhead Pharma Q2 EPS $(0.93) Beats $(1.14) Estimate, Sales $73.737M Miss $79.991M Estimate
Arrowhead Pharma (NASDAQ:ARWR) reported quarterly losses of $(0.93) per share which beat the analyst consensus estimate of $(1.14) by 18.42 percent. This is a 133.82 percent decrease over earnings of $2.75 per share from
